Wedbush reiterates Outperform on Rocket Pharmaceuticals, $15 target
Wedbush reiterated an Outperform rating on Rocket Pharmaceuticals and set a $15.00 price target.
Story updates
12:55:04 PM UTC
SquawkNews
Rocket Pharmaceuticals Price Target Maintained With a $15.00/Share by Wedbush